News
Pfizer is taking a novel tactic in its approach to the Russian war against Ukraine as CEO Albert Bourla told staffers on Wednesday that the company is putting its first ...
In September, Moderna received FDA emergency use authorization for its BA.4/BA.5-targeting bivalent booster vaccine, mRNA-1273.222, based on preclinical data for the shot as well as Phase II/III ...
The life science industry is no doubt still growing in the US, but research talent is getting more and more difficult to come by, according to the latest report from ...
As only about 11% of Americans have so far received the bivalent booster shots from Pfizer and Moderna, and only 30% of those over 65 years of age, the Biden ...
The next generation of Operation Warp Speed is coming soon, and this time it's going to take aim at rare diseases, Peter Marks, the director of the FDA's Center for ...
Rybelsus, Novo Nordisk’s GLP-1 also known as semaglutide, snagged a label update from the FDA, allowing patients to take it as a first-line treatment for Type II diabetes in 7 ...
B Capital, an investment firm co-founded by Eduardo Saverin of Facebook fame, has closed its inaugural healthcare fund. Add that to its capital growth fund, and B Capital says it ...
HHS to distribute 1.6M monkeypox vaccine doses this year ...
The FDA recently added a new warning and precaution to the label of Horizon's blockbuster monoclonal antibody Tepezza (teprotumumab-trbw), which is used as a treatment for thyroid eye disease, to ...
A federal judge in West Virginia ruled in favor of AstraZeneca on Wednesday, adding six months of patent protection for its asthma and COPD inhaler blockbuster Symbicort. The latest ruling ...
Merck KGaA's MilliporeSigma is extending a helping hand to Lotte Group as the South Korean conglomerate looks to make an impact on US soil. MilliporeSigma, Merck KGaA's life science business ...
To help meet the heightened demand for its injectable products, Eli Lilly is acquiring a facility from Nexus Pharmaceuticals, with production anticipated to start at the end of next year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results